GPT and gallstones: (1) For dose intensity [40 mg·m2: 43.8% (46/105) vs 30 mg·m2: 19.3% (12/62), P = 0.001], history of gallstones (P = 0.025), ALT (30.28 ± 15.93 U/L vs 14.14 ± 4.91 U/L, P = 0.000), AST (29.17 ± 8.79 U/L vs 19.27 ± 4.29 U/L, P = 0.000), and GGT (46.24 ± 35.60 U/L vs 19.23 ± 7.38 U/L, P = 0.000), the differences were not statistically significant.